SUPPLIER
SECTION I - PRODUCT IDENTIFICATION |
| PRODUCT NAME: | Scandium iodide, powder and pieces |
| PRODUCT CODE: | S-MSDS0067 |
| REFERENCE #: | 14474-33-0 |
| MANUFACTURER INFORMATION | |
| COMPANY NAME: | Materion Advanced Chemicals Inc. |
| 1316 W. St. Paul Avenue | |
| Milwaukee, WI 53233 | |
| EMERGENCY CONTACT: | CHEMTREC (800)424-9300 |
| ALTERNATE EMERGENCY CONTACT: | Materion Advanced Chemicals Inc. (414)289-9800 |
| CHEMICAL FAMILY: | Metal halide |
| CAS NUMBER: | 14474-33-0 |
| FORMULA: | ScI3 |
| MOLECULAR WEIGHT: | 425.67 |
| SYNONYMS | |
|
Scandium iodide; scandium triiodide anhydrous . |
|
SECTION II - HAZARDOUS INGREDIENTS/IDENTITY INFORMATION |
| Hazardous Components (Chemical Name) | CAS # | Concentration | OSHA PEL | ACGIH TLV | Other Limits |
|---|---|---|---|---|---|
| Scandium iodide | 14474-33-0 | 0.0 -100.0 % | NE | NE | NE |
SECTION III - PHYSICAL/CHEMICAL CHARACTERISTICS |
| PHYSICAL STATES: | [ ] Gas [ ] Liquid [ X ] Solid |
| MELTING POINT: | N.A. |
| BOILING POINT: | N.A. |
| SPECIFIC GRAVITY (WATER = 1): | NE |
| VAPOR PRESSURE (VS. AIR OR MM HG): | NA |
| VAPOR DENSITY (VS. AIR = 1): | NA |
| EVAPORATION RATE (VS BUTYL ACETATE=1): | NA |
| SOLUBILITY IN WATER: | NE |
| SOLUBILITY NOTES | |
| PERCENT VOLATILE: | N.A. |
| APPEARANCE AND ODOR | |
|
Powder and pieces, no odor. . |
|
SECTION IV - FIRE AND EXPLOSION HAZARD DATA |
| FLASH PT: | N.A. Method Used: Unknown |
| EXPLOSIVE LIMITS: | LEL: NE UEL: NE |
| EXTINGUISHING MEDIA | |
|
USE: Not applicable. Use suitable extinguishing media for surrounding material and type of fire. . |
|
| SPECIAL FIRE FIGHTING PROCEDURES | |
|
Firefighters must wear full face, self-contained breathing apparatus with full protective clothing to prevent contact with skin and eyes. Fumes from fire are hazardous. Isolate runoff to prevent environmental pollution. . |
|
| UNUSUAL FIRE AND EXPLOSION HAZARDS | |
|
When heated to decomposition, scandium iodide may emit toxic fumes of iodine and iodine compounds. . |
|
| HAZARDOUS COMBUSTION PRODUCTS | |
SECTION V - REACTIVITY DATA |
| STABILITY: | Unstable [ ] Stable [ X ] |
| CONDITIONS TO AVOID - INSTABILITY | |
|
None . |
|
| INCOMPATIBILITY - MATERIALS TO AVOID | |
|
None recorded . |
|
| HAZARDOUS DECOMPOSITION OR BYPRODUCTS | |
|
Iodine and iodine compounds . |
|
| HAZARDOUS POLYMERIZATION: | Will occur [ ] Will not occur [ X ] |
| CONDITIONS TO AVOID - HAZARDOUS POLYMERIZATION | |
|
None . |
|
SECTION VI - HEALTH HAZARD DATA |
| HEALTH HAZARDS (ACUTE AND CHRONIC) | |
|
To the best of our knowledge the chemical, physical and toxicological properties of scandium iodide have not been thoroughly investigated and recorded. Scandium is considered to have similar properties as rare earth metals. These metals are moderately to highly toxic. The symptoms of toxicity of the rare earth elements include writhing, ataxia, labored respiration, walking on the toes with arched back and sedation. The rare earth elements exhibit low toxicity by ingestion exposure. However, the intraperitoneal route is highly toxic while the subcutaneous route is poison to moderately toxic. The production of skin and lung granulomas after exposure to them requires extensive protection to prevent such exposure. (Sax, Dangerous Properties of Industrial Materials, eighth edition) Prolonged absorption of iodides may produce "iodism" which is manifested by skin rash, running nose, headache and irrritation of mucous memebranes. In severe cases, the skin may show pimples, boils, redness, black and blue spots, hives and blisters. Weakness, anemia, loss of weight and general depression may occur. Generally very soluble in water and easily absorbed into the body. (Sax, Dangerous Properties of Industrial Materials, eighth edition) INHALATION: Acute: May cause irritation to the respiratory tract, mucous membrane, lacrimation, headache and tight chest. Dusts may cause asthma attacks and lung damage such as lung granulomas. Large doses may cause immediate defecation, writhing, loss of muscle coordination, labored respiration, sedation, hypotension and cardiovascular failure. Chronic: Prolonged or repeated inhalation may cause writhing, loss of muscle coordination, labored respiration, sedation, hypotension, pneumonoconiosis and cardiovascular failure. INGESTION: Acute: May cause gastrointestinal irritation, abdominal pain and diarrhea. Chronic: May affect the coagulation rate of the blood. May cause gastritis, degeneration of the liver and kidneys, growth retardation, anemia and spasms. SKIN: Acute: May cause irritation, rashes and skin granulomas. Chronic: May cause dermatitis, sensitivity to heat, pimples, boils, redness, black and blue spots, hives, blisters and skin lesions. EYE: Acute: May cause irritation. Chronic: No chronic health effects recorded. TARGET ORGANS: May affect the respiratory system, liver, kidneys, blood and skin. |
|
| CARCINOGENICITY: | NTP? No IARC Monographs? No OSHA Regulated? No |
| RECOMMENDED EXPOSURE LIMITS | |
|
See "Section II" |
|
| LD 50 / LC 50 | |
|
No toxicity data recorded |
|
| SIGNS AND SYMPTOMS OF EXPOSURE | |
|
INHALATION: May cause throat dryness, cough, running nose, headache, vomiting, chest pain, irritability, depression, pneumonitis, writhing, loss of weight and muscle coordination, labored respiration, sedation, hypotension and cardiovascular failure. INGESTION: May cause nausea, choking, anemia, vomiting, diarrhea, abdominal burning and cramp-like pain. SKIN: May cause redness, itching, burning sensation, pimples, boils, black and blue spots, hives and blisters. EYE: May cause redness, itching, burning sensation and watering. . |
|
| MEDICAL CONDITIONS GENERALLY AGGRAVATED BY EXPOSURE | |
|
Pre-existing respiratory, gastric and skin disorders. . |
|
| EMERGENCY AND FIRST AID PROCEDURES | |
|
INHALATION: Remove victim to fresh air; keep warm and quiet; give oxygen if breathing is difficult and seek medical attention if symptoms persist. INGESTION: Give 1-2 glasses of milk or water and induce vomiting; seek medical attention if symptoms persist. Never induce vomiting or give anything by mouth to an unconscious person. SKIN: Remove contaminated clothing; brush material off skin; wash affected area with mild soap and water; seek medical attention if symptoms persists. EYE: Flush eyes with lukewarm water, lifting upper and lower eyelids, for at least 15 minutes. Seek medical attention if symptoms persists. . |
|
SECTION VII - PRECAUTIONS FOR SAFE HANDLING AND USE |
| STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED | |
|
Wear appropriate respiratory and protective equipment specified in section VIII-control measures. Isolate spill area and provide ventilation. Vacuum up spill using a high efficiency particulate absolute (HEPA) air filter and place in a closed container for proper disposal. Take care not to raise dust. . |
|
| WASTE DISPOSAL METHOD | |
|
Dispose of in accordance with local, state and federal regulations. . |
|
| HAZARD LABEL INFORMATION: | |
| Store in cool, dry area Store in tightly sealed container Wash thoroughly after handling | |
| PRECAUTIONS TO BE TAKEN IN HANDLING | |
|
None |
|
| PRECAUTIONS TO BE TAKEN IN STORING | |
| OTHER PRECAUTIONS | |
|
None |
|
SECTION VIII- CONTROL MEASURES |
| PROTECTIVE EQUIPMENT SUMMARY - HAZARD LABEL INFORMATION: | |
| NIOSH approved respirator Impervious gloves Safety glasses Clothes to prevent skin contact | |
| RESPIRATORY EQUIPMENT (SPECIFY TYPE) | |
|
NIOSH - approved dust respirator |
|
| EYE PROTECTION | |
|
Safety glasses |
|
| PROTECTIVE GLOVES | |
|
Rubber gloves |
|
| OTHER PROTECTIVE CLOTHING | |
|
Protective gear suitable to prevent contamination |
|
| VENTILATION | |
|
Local Exhaust: To maintain concentration at low levels Special: None Mechanical (Gen): Recommended Other: None |
|
| WORK/HYGIENIC/MAINTENANCE PRACTICES | |
|
Implement engineering and work practice controls to reduce and maintain concentration of exposure at low levels. Use good housekeeping and sanitation practices. Do not use tobacco or food in work area. Wash thoroughly before eating and smoking. Do not blow dust off clothing or skin with compressed air. . |
SECTION IX - ADDITIONAL COMMENTS |
| No data available. |